Trials / Conditions / Chronic Myelomonocytic Leukemia-1
Chronic Myelomonocytic Leukemia-1
5 registered clinical trials studyying Chronic Myelomonocytic Leukemia-1 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) NCT06950034 | Solu Therapeutics, Inc | Phase 1 |
| Active Not Recruiting | Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloprolifera NCT05038592 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Active Not Recruiting | Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia NCT04734990 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Active Not Recruiting | Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malign NCT03682029 | Rigshospitalet, Denmark | N/A |
| Active Not Recruiting | Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic S NCT01522976 | National Cancer Institute (NCI) | Phase 2 |